Vivo Bio Tech Limited (VIVOBIOT.BO)
INR 36.76
(-0.03%)
INR 36.76
(-0.03%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 827.33 Million INR | 16.26% |
| 2022 | 711.6 Million INR | -5.56% |
| 2021 | 753.53 Million INR | 103.7% |
| 2020 | 369.92 Million INR | 20.63% |
| 2019 | 306.65 Million INR | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 Q2 | 682.99 Million INR | 0.0% |
| 2023 Q4 | 827.33 Million INR | 0.0% |
| 2023 FY | 827.33 Million INR | 16.26% |
| 2022 Q4 | 711.6 Million INR | 0.0% |
| 2022 FY | 711.6 Million INR | -5.56% |
| 2022 Q2 | 727.01 Million INR | 0.0% |
| 2021 Q2 | 356.04 Million INR | 0.0% |
| 2021 FY | 753.53 Million INR | 103.7% |
| 2021 Q4 | 753.53 Million INR | 0.0% |
| 2020 FY | 369.92 Million INR | 20.63% |
| 2020 Q4 | 369.92 Million INR | 0.0% |
| 2020 Q2 | 340.33 Million INR | 0.0% |
| 2019 FY | 306.65 Million INR | 0.0% |
| 2019 Q2 | 293.09 Million INR | 0.0% |
| 2019 Q4 | 306.65 Million INR | 0.0% |
| 2018 Q4 | 280.39 Million INR | 0.0% |
| 2017 Q2 | 372.28 Million INR | 0.0% |
| 2017 Q4 | 402.02 Million INR | 0.0% |
| 2016 Q4 | 385.43 Million INR | 0.0% |
| 2016 Q2 | 307.92 Million INR | 0.0% |
| 2015 Q4 | 355.95 Million INR | 0.0% |
| 2015 Q2 | 344.79 Million INR | 0.0% |
| 2014 Q4 | 322.51 Million INR | 0.0% |
| 2013 Q4 | 315.17 Million INR | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Chandra Bhagat Pharma Limited | 727.95 Million INR | -13.652% |
| Checkpoint Trends Limited | 4 Million INR | -20545.951% |
| Everest Organics Limited | 1.8 Billion INR | 54.261% |
| GUJARAT INJECT (KERALA) LTD. | 1.47 Million INR | -56143.304% |
| NATURO INDIABULL LIMITED | 537.34 Million INR | -53.968% |
| NEXUS SURGICAL AND MEDICARE LI | 12.39 Million INR | -6572.116% |
| Rajnish Wellness Limited | 222.75 Million INR | -271.409% |
| Rama Vision Limited | 291.78 Million INR | -183.54% |